Trulieve Announces Conditional Approval for Texas License

Rhea-AI Summary

Trulieve (OTCQX: TCNNF) announced on Dec 3, 2025 that the Texas Department of Public Safety granted conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program.

If finalized, Trulieve TX will be authorized to cultivate, manufacture, and distribute medical cannabis in Texas, expanding patient access. The license remains subject to final approval by the Texas Department of Public Safety and standard regulatory completion steps.

Positive

• Conditional Dispensing Organization license in Texas
• Authorized to cultivate, manufacture, and distribute medical cannabis

Negative

• License is only conditionally approved and needs final DPS sign-off
• Final approval risk could delay or prevent Texas market entry

TALLAHASSEE, Fla., Dec. 3, 2025 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the Texas Department of Public Safety granted Trulieve TX, Inc. conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. As a licensed Dispensing Organization, Trulieve will cultivate, manufacture, and distribute high quality medical cannabis products to Texas patients. The license is subject to final approval by the Texas Department of Public Safety.

"We are excited to be selected for a coveted Texas Dispensing Organization license and we look forward to working with regulators as we complete the licensing process," said Kim Rivers, CEO of Trulieve. "Pending necessary approvals, we plan to provide patients compassionate care and expanded access to high quality medical cannabis products."

Trulieve remains committed to supporting the communities in which we operate. For more information on our community efforts, please visit https://www.trulieve.com/about/our-mission.

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve
X: @Trulieve

Investor and Media Contact
Christine Hersey, Vice President of Investor Relations
+1 (424) 202-0210
Christine.Hersey@Trulieve.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/trulieve-announces-conditional-approval-for-texas-license-302631141.html

SOURCE Trulieve Cannabis Corp.

FAQ

What did Trulieve (TCNNF) announce on Dec 3, 2025 about Texas licensing?

Trulieve said it received conditional approval for a Texas Dispensing Organization license from the Texas Department of Public Safety.

What activities will Trulieve (TCNNF) be allowed to do under the Texas Dispensing Organization license?

Pending final approval, Trulieve TX will be able to cultivate, manufacture, and distribute medical cannabis to Texas patients.

Is Trulieve's (TCNNF) Texas license final and immediately effective?

No; the license is subject to final approval by the Texas Department of Public Safety and completion of the licensing process.

How could the conditional Texas license affect Trulieve (TCNNF) investors?

The conditional license signals potential market expansion into Texas, but outcomes depend on final regulatory approval and timing.

Where can investors find more information about Trulieve's (TCNNF) community efforts mentioned on Dec 3, 2025?

Investors can visit Trulieve's website for community and mission details at the company's About / Our Mission page.